Literature DB >> 9520420

Packaging of intron-containing genes into retrovirus vectors by alphavirus vectors.

K J Li1, H Garoff.   

Abstract

Efficient and controllable expression of a transgene usually requires the presence of intron sequences and much efforts have been made to produce retrovirus vectors that can transduce and integrate genes with introns. However, this has proven difficult because the viral RNA is spliced when it is synthesized in the nucleus of a producer cell. We describe a novel approach to avoid this problem. In our system the retroviral RNA is synthesized in the cytoplasm of the cell, not in the nucleus, in a reaction driven by the Semliki Forest virus (SFV) expression system. The approach was tested with a recombinant Moloney murine leukemia virus genome containing the chloramphenicol acetyltransferase (CAT) gene in association with an intron. This was inserted into a SFV transcription plasmid and the corresponding SFV vector RNA was transcribed in vitro. BHK-21 cells were then transfected with this vector RNA together with two additional SFV vectors that encode the Moloney murine leukemia virus packaging proteins. Retrovirus vectors containing intron-CAT sequences were produced at titers up to 1.3 x 10(6) infectious particles per ml during a 5-hr incubation period. The vectors faithfully transduced the intron-containing CAT gene into NIH 3T3 cells, where the intron-CAT RNA was subjected to efficient splicing and used for high level enzyme expression. Thus, the results show that intron containing genes can be efficiently packaged into retrovirus vectors by the SFV expression system.

Entities:  

Mesh:

Year:  1998        PMID: 9520420      PMCID: PMC19890          DOI: 10.1073/pnas.95.7.3650

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Tissue-specific expression of functionally rearranged lambda 1 Ig gene through a retrovirus vector.

Authors:  R D Cone; E B Reilly; H N Eisen; R C Mulligan
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

2.  Identification of a cell-specific transcriptional enhancer in the first intron of the mouse alpha 2 (type I) collagen gene.

Authors:  P Rossi; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors.

Authors:  K J Li; H Garoff
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Complex regulation of the muscle-specific contractile protein (troponin I) gene.

Authors:  S F Konieczny; C P Emerson
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

5.  Splicing of intervening sequences introduced into an infectious retroviral vector.

Authors:  J Sorge; S H Hughes
Journal:  J Mol Appl Genet       Date:  1982

6.  Splicing as a requirement for biogenesis of functional 16S mRNA of simian virus 40.

Authors:  P Gruss; C J Lai; R Dhar; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  Retroviral-mediated transfer of genomic globin genes leads to regulated production of RNA and protein.

Authors:  S Karlsson; T Papayannopoulou; S G Schweiger; G Stamatoyannopoulos; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Introns increase transcriptional efficiency in transgenic mice.

Authors:  R L Brinster; J M Allen; R R Behringer; R E Gelinas; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

9.  Expression of the human beta-globin gene after retroviral transfer into murine erythroleukemia cells and human BFU-E cells.

Authors:  M A Bender; A D Miller; R E Gelinas
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

10.  Position-independent, high-level expression of the human beta-globin gene in transgenic mice.

Authors:  F Grosveld; G B van Assendelft; D R Greaves; G Kollias
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

View more
  8 in total

1.  Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

Authors:  R Zufferey; J E Donello; D Trono; T J Hope
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Link between genome packaging and rate of budding for Rous sarcoma virus.

Authors:  Eric M Callahan; John W Wills
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  Mobilization of full-length Semliki Forest virus replicon by retrovirus particles.

Authors:  Eric Piver; Christine Collin; Noémie Renault; Thierry Bru; Jean-Christophe Pagès
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Split-intron retroviral vectors: enhanced expression with improved safety.

Authors:  S I Ismail; S M Kingsman; A J Kingsman; M Uden
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.

Authors:  C Konetschny; G W Holzer; F G Falkner
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 6.  Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.

Authors:  Axel Schambach; Christopher Baum
Journal:  DNA Repair (Amst)       Date:  2007-05-07

7.  Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus.

Authors:  Christian Konetschny; Georg W Holzer; Carsten Urban; Thomas Hämmerle; Josef Mayrhofer; Falko G Falkner
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles.

Authors:  Juana M Sánchez-Puig; María M Lorenzo; Rafael Blasco
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.